PharmaPrint
This article was originally published in The Tan Sheet
Executive Summary
Ken Gorelick, MD, on board as senior VP-R&D and chief medical officer at the Irvine Calif.-based developer of dietary supplements derived from natural plant extracts. Gorelick most recently was with DuPont Merck as VP, product planning & acquisition and VP, clinical R&D. He also is affiliated with Stanford University Medical School. PharmaPrint developed the line of supplements soon to be introduced by American Home Products under the Centrum banner...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning